Intermedia Capital Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Intermedia Capital Tbk. trades at Rp68 (market cap 2.71T, 62.15M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Intermedia Capital Tbk. is far larger — about 16.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Intermedia Capital Tbk. is more actively traded (62.15M versus 96.7K). Which is the better fit depends on your goals.
| MDIA | OBAT | |
|---|---|---|
Market Cap | 2.71T | 167.37B |
Volume | 62.15M | 96.7K |
Lot | 621.46K | 967 |
Turnover | 4.21B | 23.82M |
Average Price | 67.8 | 246.34 |
Value | 4.21B | 23.82M |
Indicative Equilibrium Price | 68 | 248 |
Indicative Equilibrium Volume | 21.49K | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Intermedia Capital Tbk (the Company) was established based on Notarial Deed No.5 of Firdhonal, S.H., dated February 25, 2008 under the name of PT Magazine Asia.
Read more on MDIA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →